Library

AIDS Stigma Among Health Professionals in Puerto Rico

The stigma related to HIV/AIDS poses a challenge to the lives of people living with HIV/AIDS (PLWHA). These are worsened when people who are important in the lives of PLWHA manifest it, such as health professionals. This is particularly true for physicians who represent the first line of contact for treatment and the basis of knowledge of effective strategies to treat the disease. When physicians stigmatize PLWHA access to effective treatment can be hindered.

Technology-based Adaptive Treatment Strategies for Antiretroviral Adherence

The Achilles heel of successful HIV treatment is adherence to antiretroviral (ARV) therapy, as non-adherence remains one of the strongest predictors of progression to AIDS and death. The U.S. Department of Health and Human Services, the British HIV Association, and the World Health Organization acknowledge the supportive role of technology for adherence. This recognition underscores the importance of the need for stronger evidence of the effectiveness of these technologies.

Positive Prevention in Mozambique

Facilitated by The Twinning Center, the UCSF School of Nursing has partnered with the Ministry of Health in Mozambique in order to adapt, pilot, and implement an US evidence-based Positive Prevention (PP) intervention within rural Mozambique.

PATH Project: A Randomized Controlled Trial Preparing Patients to Start Antiretroviral Therapy

The purpose of The PATH Project is to develop and test an intervention to prepare HIV+ men and women who, based on current treatment guidelines, should be but are not currently taking antiretroviral therapy (ART). The immediate goal of the intervention is to address obstacles to ART uptake.

Stonewall Treatment Evaluation Project (STEP)

The purpose of this project is to conduct a systematic program evaluation of the Stonewall Project, which is currently deployed in four community settings by the San Francisco AIDS Foundation. The Stonewall Project is an innovative, outpatient substance abuse treatment program for methamphetamine-using MSM that is implementing evidence-based interventions (i.e., the Matrix Model) in a real world clinical setting.

Social Sexual Networks and HIV Risk: Men of Color

This study will advance theoretical understandings of HIV risk behaviors by examining potential mechanisms (i.e., social networks and sexual partnerships) through which social discrimination impacts sexual risk among MSM of color and offer valuable insights for possible interventions involving both individual and structural changes.

Serosorting among Men at Risk for HIV

This study will obtain cross-sectional and longitudinal data on “HIV serosorting” among MSM in San Francisco. We broadly define HIV serosorting as diverse strategies to reduce HIV acquisition or transmission by intentionally selecting sexual partners of the same serostatus or by modifying sexual practices depending on the partner’s serostatus.

Power and Risk Among Gay Couples

In recent years, HIV prevention efforts among gay men in the US have broadened in scope to incorporate the social, cultural,interpersonal, and contextual factors associated with HIV infection and transmission.

Partner Management among Latino MSM

Literature on risk has historically focused on individual behavior (“How many partners have you had? How often do you use a condom? etc.); however recent studies have begun to recognize the need to acknowledge the social and sexual context of risk behavior. For example, studies have examined the role of partner preferences, sexual situations, partner selection, sexual stereotypes and, most recently, seroadaptive behaviors.

Multilevel Prevention in Culture and Context with Latino MSM

We are in the process of evaluating data of an HIV prevention program for Latino men who have sex with men (MSM) who do not self-identify as gay. The project relies on an established community collaborative relationship between CAPS and the City of Berkeley, CA AIDS Office, Department of Public Health.

The Acute UFO Study: Acute HCV Infection in Young Injectors

Young injection drug users (IDU) constitute a distinctive high risk and understudied group with high rates of hepatitis C virus (HCV) infection. The Acute UFO study has identified 135 incident HCV infections, 95 of which are being followed prospectively. In this study we are: Studying the epidemiology of acute HCV infection.

Study Targeting Affect Regulation (STAR)

The STAR study will develop and pilot test a multi-component intervention to promote affect regulation among HIV+ methamphetamine-using MSM. In Phase 1a of this study, the intervention will be pilot tested with 10 HIV+ methamphetamine-using MSM to obtain initial feedback that will assist with refining the protocol.

Stonewall Treatment Evaluation Project (STEP)

The purpose of this project is to conduct a systematic program evaluation of the Stonewall Project, which is currently deployed in four community settings by the San Francisco AIDS Foundation. The Stonewall Project is an innovative, outpatient substance abuse treatment program for methamphetamine-using MSM that is implementing evidence-based interventions (i.e., the Matrix Model) in a real world clinical setting.

RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users

In the era of HIV treatment as prevention (TasP), efforts are needed to identify evidence-based combination prevention approaches that achieve greater decreases HIV viral load among populations that are more likely to engage in HIV transmission risk behavior.

Estigma

¿Cómo afecta el estigma a la prevención y al tratamiento del VIH? Elaborado por Pamela DeCarlo y Maria Ekstrand PhD, CAPS | October 2016

Stigma

HIV-related stigma is a significant problem globally. HIV stigma inflicts hardship and suffering on people living with HIV and interferes with research, prevention, treatment, care and support efforts. HIV-related stigma refers to negative beliefs, feelings and attitudes towards people living with HIV, their families and people who work with them. HIV stigma often reinforces existing social inequalities based on gender, race, ethnicity, class, sexuality and culture.

Stigma (fact sheet)

How does stigma affect HIV prevention and treatment? Prepared by Pamela DeCarlo and Maria Ekstrand, PhD Community Engagement (CE) Core | October 2016

Tel-Me-Box: Validating and testing a novel, low cost, real-time monitoring device with hair level analysis among adherence-challenged patients

“Tel-Me-Box” is a small, low-cost, adherence monitoring device, developed by our team that transmits a wireless signal to a server when opened.  Since it cannot assess actual drug ingestion, validation against a biological measure of adherence is crucial.  The overarching hypothesis of this application is that adherence data captured by Tel-Me-Box will demonstrate strong relationships with an objective biomarker of adherence (i.e.

National Gay Men’s HIV/AIDS Awareness Day – September 27, 2016

This brochure lists research projects with gay men and helpful resources produced by CAPS/PRC. You might use it to: Stay up-to-date on research and learn what we found out from research Provide materials in trainings/presentations Advocate for services/funding Write grants Develop new or modify existing HIV prevention programs Evaluate current programs Connect with CAPS/PRC to develop new projects. Lead rese

National HIV Testing Day – June 27, 2016 [booklet]

This brochure lists research focusing on HIV testing and helpful resources produced by CAPS/PRC. You might use it to: Stay up-to-date on research and learn what we found out from research Use the materials in trainings/presentations Advocate for services/funding Write grants Develop new or modify existing HIV prevention programs Evaluate current programs Connect with CAPS/PRC to develop new projects. Lead re